论文部分内容阅读
目的对慢性萎缩性胃炎患者采用消化内科规范性治疗并对临床效果进行探讨。方法选取本院收治的慢性萎缩性胃炎患者117例作为本次研究对象,选取时间段为2015年10月至2016年10月,对117例患者按照就诊顺序进行编号(1-117),应用随机数字法分成对照组(n=50)和讨论组(n=67)。对照组患者常规用药治疗,讨论组患者则实施消化内科规范性治疗,对比两组患者的临床治疗效果。结果讨论组患者中治愈37例,有效27例,无效3例,治疗总有效率为95.52%,治愈率为55.22%,对照组患者中治愈17例,有效24例,无效9例,治疗总有效率为82.00%,治愈率为34.00%,讨论组治疗总有效率和治愈率均明显高于对照组,且差异较为显著,P<0.05;治疗后讨论组患者Hp转阴率为92.54%,相比对照组高出20.54%,具有明显优势,P<0.05。结论对慢性萎缩性胃炎患者进行消化内科规范性治疗,临床治疗效果明确,应在临床中进行推广普及应用。
Objective To treat patients with chronic atrophic gastritis with normative treatment of gastroenterology and to explore the clinical effect. Methods A total of 117 patients with chronic atrophic gastritis admitted to our hospital were enrolled in this study. The selected time period was from October 2015 to October 2016, and 117 patients were numbered according to the order of treatment (1-117) Numerology was divided into control group (n = 50) and discussion group (n = 67). The patients in the control group were treated with conventional drugs. The patients in the discussion group were treated with normative treatment of digestive medicine, and the clinical effects of the two groups were compared. Results In the discussion group, 37 cases were cured, 27 cases were effective and 3 cases were ineffective. The total effective rate was 95.52% and the cure rate was 55.22%. In the control group, 17 cases were cured, 24 cases were effective and 9 cases were ineffective. The effective rate was 82.00% and the cure rate was 34.00%. The total effective rate and cure rate in the treatment group were significantly higher than those in the control group, with a significant difference (P <0.05). After treatment, the Hp negative conversion rate was 92.54% 20.54% higher than the control group, with obvious advantages, P <0.05. Conclusion The treatment of chronic atrophic gastritis patients with normative treatment of gastroenterology, clinical treatment effect is clear, should be popularized in the clinical application.